NewsBenzinga据报道,Genentech 的 Divarasib 在 III 期 Krascendo 1 研究中将死亡风险降低 44%,且较 Sotorasib 或 Adagrasib 在既往治疗过的 KRAS G12C 非小细胞肺癌(NSCLC)患者中具有更少的 TRAE 导致停药(4.8% 对 11.7%) 据报道,Genentech 的 Divarasib 在 III 期 Krascendo 1 研究中将死亡风险降低 44%,且较 Sotorasib 或 Adagrasib 在既往治疗过的 KRAS G12C 非小细胞肺癌(NSCLC)患者中具有更少的 TRAE 导致停药(4.8% 对 11.7%) Benzinga 2026.10.26 07:28 (GMT+0) Open on Benzinga Other news ‘Not Under Systemic Attack’: Marco Rubio Says ‘Zero Evidence’ Microsoft, JPMorgan and FAA Outages Due to Hostile Actors Can Colette Kress Fill Jensen Huang’s Shoes? Nvidia Posts $116 Billion Quarter, but Analyst Sees ‘Bigger Test’ Ahead Trump Administration Sued by Ecuadorian Fishermen Over Pacific Drone Strike: ‘We’re Alive by the Grace of God’ Micron Technology (MU) Stock Is Trending After Hours: Here's Why Kevin O’Leary Says Nvidia Needs Leader Who Can Manage ‘International Pressure’ as Crypto Punters Raise Odds of NVDA Stock Hitting $180 By Month-End Anthony Scaramucci Blasts Trump on FAA Meltdown: ‘Why Don’t We Start Focusing on Ourselves Now?’
‘Not Under Systemic Attack’: Marco Rubio Says ‘Zero Evidence’ Microsoft, JPMorgan and FAA Outages Due to Hostile Actors
Can Colette Kress Fill Jensen Huang’s Shoes? Nvidia Posts $116 Billion Quarter, but Analyst Sees ‘Bigger Test’ Ahead
Trump Administration Sued by Ecuadorian Fishermen Over Pacific Drone Strike: ‘We’re Alive by the Grace of God’
Kevin O’Leary Says Nvidia Needs Leader Who Can Manage ‘International Pressure’ as Crypto Punters Raise Odds of NVDA Stock Hitting $180 By Month-End